Gamma-butyrolactone (GBL) dependence and withdrawal

Addiction

Volumn 106, Issue 2, 2011, Pages 442-447

  Bell, James ^a   Collins, Rodney ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dependence; Gamma butyrolactone; GBL; GHB; Withdrawal

Indexed keywords

BACLOFEN; CENTRAL MUSCLE RELAXANT; DIAZEPAM; GAMMA BUTYROLACTONE; SOLVENT;

ADDICTION; ADULT; AMBULATORY CARE; ARTICLE; CHEMICALLY INDUCED DISORDER; DELIRIUM; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; MALE; OUTPATIENT DEPARTMENT; RECURRENT DISEASE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

4-BUTYROLACTONE; ADULT; AMBULATORY CARE; BACLOFEN; DELIRIUM; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALIZATION; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; OUTPATIENT CLINICS, HOSPITAL; RECURRENCE; SOLVENTS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650804005     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03145.x     Document Type: Article

References (11)

1. Galloway G. P., Frederick S. L., Staggers F. E., Jr, Gonzales M., Stalcup S. A., Smith D. E. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92: 89-96.
2. McDaniel C. H., Miotto K. A. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. J Psychoactive Drugs 2001; 33: 143-9.
3. Munir V. L., Hutton J. E., Harney J. P., Buykx P., Weiland T. J., Dent A. W. Gamma-hydroxybutyrate: a 30 month emergency department review. Emerg Med Aust 2008; 20: 521-30.
4. Van Sassenbroeck D. K., De Neve N., De Paepe P., Belpaire F. M., Verstraete A. G., Calle P. A. et al. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series. Clin Toxicol 2007; 45: 533-8.
5. Wojtowicz J. M., Yarema M. C., Wax P. M. Withdrawal from gamma-hydroxybutyrate, 1, 4-butanediol and gamma-butyrolactone: a case report and systematic review. Can J Emerg Med 2008; 10: 69-74.
6. Palmer R. B. Gammabutyrolactone and 1, 4 butanediol. Toxicol Rev 2004; 23: 21-31.
7. McDonough M., Kennedy N., Glasper A., Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004; 75: 3-9.
8. Dyer J. E., Roth B., Hyma B. A. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37: 147-53.
9. Zepf F. D., Holtmann M., Duketis E., Maier J., Radeloff D., Schirman S. et al. Withdrawal syndrome after abuse of GHB (gamma-hydroxybutyrate) and its physiological precursors-its relevance for child and adolescent psychiatrists. Zeitschr Kinder Jugendpsychiatr Psychother 2009; 37: 413-20.
10. Bennett W. R., Wilson L. G., Roy-Byrne P. P. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report. J Psychoact Drugs 2007; 39: 293-6.
11. LeTourneau J. L., Hagg D. S., Smith S. M. Baclofen and gamma-hydroxybutyrate withdrawal. Neurocrit Care 2008; 8: 430-3.